top of page

advancing REMISSION

Brain 2.jpg

TRRN designs and engages in translational research in order to inform clinical practice and develop protocols that have practical applications.

CURRENT STUDIES

Screening, Brief Intervention, and Referral to Treatment in a Retail Pharmacy Setting

TRRN PUBLICATIONS

1. Brian C. Shonesy, Donald Williams, Damien Simmons, Erin Dorval, Stuart Gitlow, & Richard M. Gustin. 2019. Screening, Brief Intervention, and Referral to Treatment (SBIRT) in a retail pharmacy setting: The Pharmacist’s role in identifying and addressing risk of substance use disorder. Journal of Addiction Medicine. March 9.

2. Richard M. Gustin & Eric Wish. 2018. Uninsured Opioid Users Admitted to Medication-Assisted Treatment (MAT) Program in Palm Beach, Florida, Found to Be Using Many Drugs in Addition to Opioids. DOTS (Drug Outbreak Testing Services) Bulletin 5: 1-2

3. Richard M. Gustin, Jake P. Nichols, Peter R. Martin. 2015. Individualizing Opioid Use Disorder (OUD) Treatment: Time to Fully Embrace a Chronic Disease Model. Journal of Reward Deficiency Syndrome 1(1): 10-15.

CONSULTATION SERVICES

TRRN offers substance use disorder consulting to a variety of stakeholders from pharmaceutical & biotechnology companies, hospital systems, legislators, community and advocacy groups, criminal justice systems, among others.

To see how TRRN can help support your specific initiatives,

please call us at (561) 812-2001 or email us at info@TRRN.org

We are always happy to have an introductory discussion on how we can collaborate!

bottom of page